UPDATE: Evercore ISI Downgrades Phathom Pharmaceuticals (PHAT) to In Line
Tweet Send to a Friend
(Updated - May 6, 2022 9:35 AM EDT)
Evercore ISI analyst Umer Raffat downgraded Phathom Pharmaceuticals (NASDAQ: PHAT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Evercore ISI analyst Umer Raffat downgraded Phathom Pharmaceuticals (NASDAQ: PHAT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
